Frank McCormick's Net Worth

$52.7 Million

Estimate Recalculated Jul 12, 2024 04:17PM EST

Who is Frank McCormick?

Frank McCormick has an estimated net worth of $52.7 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., BridgeBio Pharma, Inc., ADURO BIOTECH, INC., and Olema Pharmaceuticals, Inc..

SEC CIK

Frank McCormick's CIK is 0001257809

Past Insider Trading and Trends

2019 was Frank McCormick's most active year for acquiring shares with 6 total transactions. Frank McCormick's most active month to acquire stocks was the month of April. 2019 was Frank McCormick's most active year for disposing of shares, totalling 16 transactions. Frank McCormick's most active month to dispose stocks was the month of November. 2003 saw Frank McCormick paying a total of $207,250.00 for 25,000 shares, this is the most they've acquired in one year. In 2020 Frank McCormick cashed out on 319,217 shares for a total of $4,275,768.84, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EXELIXIS, INC. (EXEL) Snapshot price: $20.3675

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 6
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
Apr 23
Form 4
—
0
—
—
0
Apr 9
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jul 29
No matching records found

BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.72

Chairman Oncology

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
-13.74%
-100.00K
$42.06
-$4,206,000.00
627.69K
Scheduled
Dec 26
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Feb 21
Form 4
-7.69%
-100.00K
$42.76
-$4,275,768.84
1.2M
Nov 13
Form 4
+3.09%
39.04K
—
—
1.3M
May 19
Form 4
-3.79%
-100.00K
$36.86
-$3,755,379.27
2.54M
Scheduled
Dec 27 - Dec 30
Form 4
∞
1.36M
—
—
1.36M
Jul 1
Form 3
—
0
—
—
0
No matching records found

ADURO BIOTECH, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Apr 14
Form 3
—
0
—
—
0
No matching records found

Olema Pharmaceuticals, Inc. (OLMA) Snapshot price: $15.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+390.37%
219.22K
—
—
275.37K
Nov 23
Form 4
—
0
—
—
0
Sep 18 - Nov 18
Form 3
—
0
—
—
0
No matching records found